There aren't many opportunities for CSL to grow by acquisition, so the way to boost the share price is to keep buying back shares and increasing value for shareholders... If they have the money then why not? Personally I think opportunities in stem cell research is a good way to diversify away from plasma products and MSB as a takeover target, but that's my personal opinion... I don't think any shareholders would complain about the recent and past share price performance, it has been sensational and so have the management... I should also point out that I am employed by CSL and have been working there for the past 6 years...
There aren't many opportunities for CSL to grow by acquisition,...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$288.80 |
Change
-0.300(0.10%) |
Mkt cap ! $139.5B | |||
| Open | High | Low | Value | Volume |
| $288.06 | $290.40 | $287.86 | $189.1M | 654.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $288.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $288.81 | 1380 | 2 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$288.01 |
Change
-0.300 ( 0.37 %) |
||||
| Open | High | Low | Volume | ||
| $288.40 | $290.39 | $287.66 | 103444 | ||
| Last updated 15.59pm 17/06/2024 ? | |||||
| CSL (ASX) Chart |
